Price target
110.400.00 0.00%
The 5 analysts offering 1 year price forecasts for 0RC7 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0RC7 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0RC7 EPS for the last quarter is −4.15 SEK despite the estimation of −3.46 SEK. In the next quarter EPS is expected to reach −2.78 SEK. Track more of HANSA BIOPHARMA AB NPV financials and stay on top of what is up with the company.
In the next quarter HANSA BIOPHARMA AB NPV revenue is expected to reach 54.27 M SEK. Check out HANSA BIOPHARMA AB NPV revenue and earnings and make informed decisions.
According to analysts, 0RC7 price target is 110.40 SEK with a max estimate of 175.00 SEK and a min estimate of 68.00 SEK. Check if this forecast comes true in a year, meanwhile watch HANSA BIOPHARMA AB NPV stock price chart and keep track of the current situation with 0RC7 news and stock market news.
We've gathered opinions of 5 analysts rating 0RC7 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.